| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1564682A Compositions for potentiating glutatthione |
| 01/12/2005 | CN1564679A Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 01/12/2005 | CN1563010A Method for preparing inophyllolide C2 and application of preparing medication of anti SARS |
| 01/12/2005 | CN1562992A Technique for extracting general coumarin and monomer components from cnidium fruit and medicinal preparation |
| 01/12/2005 | CN1562366A SARS nucleic acid vaccine and preparation method, application of S gene in coronavirus |
| 01/12/2005 | CN1562365A SARS vaccine of adenovirus carrier and preparation method, application of coronavirus S gene |
| 01/12/2005 | CN1562333A Chinese traditional medicine for treating pulmonary heart disease |
| 01/12/2005 | CN1562317A Medicination for relieving cough and asthma |
| 01/12/2005 | CN1562307A Method for preparing compound licorice buccal tablet |
| 01/12/2005 | CN1562303A Soft capsules of guifu dihuang and preparation method |
| 01/12/2005 | CN1562301A Chinese traditional medicine for treating atypical pneumonia |
| 01/12/2005 | CN1562296A Combination of Chinese herbal medicine for curing chronic tracheitis and chronic bronchitis |
| 01/12/2005 | CN1562273A Method for producing compound Geqing capsule or granule |
| 01/12/2005 | CN1562256A Prepared Chinese medicine for treating upper respiratory tract infection |
| 01/12/2005 | CN1562233A Dispersion tablet of root of indian stringbush and preparation method |
| 01/12/2005 | CN1562218A Medication combination of compound tea tree oil for preventing or curing inflammation of human genital tract |
| 01/12/2005 | CN1562217A Aqueous extract of irid and usage |
| 01/12/2005 | CN1562203A Remedy for curing acute pharyngitis and its prepn. tech |
| 01/12/2005 | CN1562181A Chinese medica preparation for curing common cold and cough and preparation method |
| 01/12/2005 | CN1562180A Preparation of Chinese traditional medicine for curing cough and preparation method |
| 01/12/2005 | CN1562173A Technique for producing extract product of mulberry bark |
| 01/12/2005 | CN1562172A Capsule of Chinese traditional medicine for treating cough and asthma, and preparation method |
| 01/12/2005 | CN1562156A White flagger oral liquid and its preparing method |
| 01/12/2005 | CN1562153A Method for preparing Herba Lycopi extract with anti-oxygen dificit function |
| 01/12/2005 | CN1562151A Medicinal formulation for treating upper respiratory track infection and its design method |
| 01/12/2005 | CN1562141A Chinese medicine compound preparation for treating cough and its preparing method |
| 01/12/2005 | CN1562120A Medicine for treating nasosinusitis |
| 01/12/2005 | CN1562103A Medicine for treating nasosinusitis and preparing method |
| 01/12/2005 | CN1562087A Amphioxus preparation for treating lung cancer, chronic bronchitis and bronchial asthma, and preparing method |
| 01/12/2005 | CN1562069A Use of C-ski gene and its polypeptide in preparing medicine for improving tissue repairing and reducing scar formation |
| 01/12/2005 | CN1561985A Novel sodium houttuyfonate powder injection |
| 01/12/2005 | CN1561982A Bumetanide dripping pill and its preparing method |
| 01/12/2005 | CN1561978A Hexoprenaline hydrochloride dripping pill and its preparing method |
| 01/12/2005 | CN1561977A Chlorpronaline hydrochloride dripping pill and its preparing method |
| 01/12/2005 | CN1184304C Health wine |
| 01/12/2005 | CN1184204C Piperidine compounds for use as CCR-3 inhibitors |
| 01/12/2005 | CN1184196C Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 01/12/2005 | CN1183942C Chinese medicine pill for treating cough |
| 01/11/2005 | US6841698 Aminopropylphosphinic acids |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841571 Compounds useful as reversible inhibitors of cysteine proteases |
| 01/11/2005 | US6841567 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | US6840243 Methods and devices for use in performing pulmonary procedures |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/11/2005 | CA2069870E Treatment of atopic disorders with gamma-interferon |
| 01/06/2005 | WO2005000829A1 Cannabinoid receptor modulator |
| 01/06/2005 | WO2005000825A1 Thiazolimine compound and oxazolimine compound |
| 01/06/2005 | WO2005000822A1 N-{‘4-substituted piperazine-1-sulfonylmethyl!alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | WO2005000815A2 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor |
| 01/06/2005 | WO2005000300A1 Substituted 5-membered ring compounds and their use |
| 01/06/2005 | WO2004096800A3 Quinuclidine derivatives binding to mucarinic m3 receptors |
| 01/06/2005 | WO2004082574A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d5 (drd5) |
| 01/06/2005 | WO2004073586A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor tg1019 (tg1019) |
| 01/06/2005 | WO2004071392A3 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 01/06/2005 | WO2004071388A3 Medicinal compounds |
| 01/06/2005 | WO2004071378A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | US20050004363 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 01/06/2005 | US20050004216 Treating asthma, chronic obstructive pulmonary disease and/or other respiratory difficulties |
| 01/06/2005 | US20050004207 Substituted isoindoles and the use thereof |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004202 Such as 3-[1-(3-methoxypropyl )-1H-indazol-3-yl]-4-[1-(3-pyridinyl )-1H-indol-3-yl]-1H-pyrrole-2,5-dione; protein kinase C and/or glycogen synthase kinase-3 diseases |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004195 Inhibitors of phosphoinositide 3 kinases; inflammatory diseases, cardiovascular disorders, cancers; such as 5,6-dimethoxy-3-o-tolylsulfanyl-1H-indole-2-carboxylic acid-(2H-tetrazol-5-yl)-amide |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004159 for example, 8-(1-ethylpropyl)-3-mesityl-2,5-dimethyl-8H-pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine; having an excellent corticotrophin-releasing-factor receptor antagonistic activity |
| 01/06/2005 | US20050004154 1,2,8-Triazaspiro{decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004149 Pyrimidine compound and medicinal composition thereof |
| 01/06/2005 | US20050004147 Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it |
| 01/06/2005 | US20050004140 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
| 01/06/2005 | US20050004135 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 01/06/2005 | US20050004134 Adenosine antagonists; having 6-oxo-1,6-dihydro-3-pynidazinyl functionality; synthesis |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | US20050004132 Pain, immune diseases, inflammatory disorders; low toxicity; such as 1-[2-(3-(4-Pyridyl)phenyl)ethyl]-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine 1-oxide |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004120 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 01/06/2005 | US20050004119 Trypsin like serine protease enzyme inhibitors |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004096 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004047 Bactericides; antiprotozoa agents |
| 01/06/2005 | US20050004035 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 01/06/2005 | US20050003003 Modulation of release from dry powder formulations |
| 01/06/2005 | US20050003002 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 01/06/2005 | US20050002950 Vaccine preventing infection |
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002901 Compositions and methods for treating coronavirus infection and SARS |
| 01/06/2005 | CA2531020A1 Cannabinoid receptor modulator |
| 01/06/2005 | CA2529468A1 N-{[4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/05/2005 | EP1493745A1 New crystalline and amorphous form of a triazolo(4,5-D)pyrimidine compound |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493740A1 5-fluoro-thiophene compounds, the process for their prepartion, the pharmaceutical compositions containing them and their use as metalloproteinases inhibitors |
| 01/05/2005 | EP1493739A1 Thiophene derivatives of aminoacids, process for the preparation thereof and compositions containing them |
| 01/05/2005 | EP1493732A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions |
| 01/05/2005 | EP1492883A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |